Variable | Culprit lesions in UAP | p Value | Non-culprit lesions in UAP | p Value | Lesions with SAP | p Value | |||
NV (n=32) | No NV (n=60) | NV (n=70) | No NV (n=133) | NV (n=17) | No NV (n=44) | ||||
TCFA, n (%) | 26 (81) | 28 (47) | 0.002 | 27 (39) | 56 (42) | 0.62 | 7 (41) | 19 (43) | 0.90 |
Fibrous cap thickness, μm | 56±20 | 75±30 | <0.001 | 90±44 | 97±61 | 0.36 | 83±36 | 93±61 | 0.48 |
Lipid core arc° | 254±66 | 222±65 | 0.02 | 186±68 | 178±64 | 0.13 | 204±62 | 211±61 | 0.82 |
Lipid core length, mm | 13±5 | 10±6 | 0.007 | 9±6 | 8±4 | 0.11 | 10±4 | 9±6 | 0.51 |
Calcification, n (%) | 11 (34) | 22 (37) | 0.83 | 29 (41) | 41 (31) | 0.24 | 7 (41) | 13 (30) | 0.50 |
Disruption, n (%) | 18 (56) | 31 (52) | 0.67 | 6 (9) | 8 (6) | 0.51 | 1 (6) | 4 (9) | 0.76 |
Thrombus, n (%) | 16 (50) | 36 (60) | 0.36 | 5 (7) | 9 (7) | 0.95 | 3 (18) | 3 (7) | 0.17 |
Data are presented as mean ± SD, n (%).
NV, neovascularisation; SAP, stable angina pectoris; TCFA, thin cap fibroatheroma; UAP, unstable angina pectoris.